Pooling multiple pharmaceutical companies' assets across a given therapeutic area will allow industry to make rational R&D investment ... The executives, as the highest decision-makers in the company, directly influence corporate research and development (R&D) investment and innovation ... MS Pharma today announced that Olayan Financing Company (OFC) has made a minority equity investment in the company.
This profile has not yet been verified by the firm. Information may be incomplete or outdated. Claim this profile to take control of your listing.
Claim this profile to complete your information, set investment criteria, and start receiving curated deal flow from sponsors on DEALITHIC.